Physician profile
Preya Simlote
NPI 1922494046
$5,814.06
in general payments reported to CMS, 2019-2025
31 companies · $2,231 in 2025
The $2,231 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $208 · 2021: $338 · 2022: $437 · 2023: $1,020 · 2024: $1,348 · 2025: $2,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,598.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $889.05 | 2025 | Rapiblyk |
| Abbott Laboratories | $775.54 | 2019-2024 | Pressurewire, Coroflow |
| Novartis Pharmaceuticals Corporation | $529.79 | 2021-2025 | |
| Pfizer INC. | $494.88 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $418.05 | 2022-2025 | Jardiance |
| Novo Nordisk INC | $334.60 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $260.86 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $256.99 | 2022-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $254.47 | 2022-2025 | Lifevest |
| Amgen INC. | $208.75 | 2022-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $204.06 | 2021-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $177.39 | 2022-2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $173.39 | 2023-2025 | Watchman Access System, Varithena Administration Pack |
| Medtronic, INC. | $130.09 | 2021-2025 | Aurora Ev-Icd Mri Surescan |
| Baxter Healthcare | $110.46 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $75.51 | 2023-2024 | |
| Atricure, INC. | $69.91 | 2021-2024 | |
| Abiomed | $64.74 | 2024 | Impella |
| Sanofi-Aventis U.S. LLC | $57.07 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $46.15 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $44.34 | 2023 | Cardiva Vascade 6/7f Vcs |
| Bridgebio Pharma, INC. | $39.18 | 2025 | Attruby |
| Actelion Pharmaceuticals US, INC. | $34.04 | 2023 | Opsumit |
| Angiodynamics, INC. | $30.38 | 2025 | Alphavac |
| Biosense Webster, INC. | $23.38 | 2025 | Carto 3 |
| Irhythm Technologies, INC. | $23.24 | 2023 | Zio Xt Patch |
| Lantheus Medical Imaging, INC. | $22.36 | 2024 | |
| Kestra Medical Technology Services, INC. | $20.75 | 2023 | Assure Wcd |
| Philips North America LLC | $15.75 | 2023 | |
| Esperion Therapeutics, INC. | $15.66 | 2024 | Nexletol |
| Currax Pharmaceuticals LLC | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preya Simlote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.